New drug shows promise in slowing brain metastases from lung cancer
Disease control
Completed
This study tested if a new drug, AZD3759, could control advanced lung cancer that had spread to the brain better than standard drugs. It involved nearly 500 adults with a specific genetic mutation (EGFR+) who had not yet received treatment for their advanced cancer. The main goal…
Phase: PHASE2, PHASE3 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 05:56 UTC